Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Trimedoxime bromide

From Wikipedia, the free encyclopedia
(Redirected from TMB-4)
Trimedoxime bromide
Clinical data
Routes of
administration
Intramuscular injection
ATC code
  • None
Legal status
Legal status
  • Experimental; in military use
Pharmacokinetic data
Elimination half-life2 hours (mean)
Identifiers
  • 1,1-propane-1,3-diylbis{4-[(E)-(hydroxyimino)methyl]pyridinium} dibromide
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.000.276 Edit this at Wikidata
Chemical and physical data
FormulaC15H18Br2N4O2
Molar mass446.143 g·mol−1

Trimedoxime bromide (INN), also known as dipyroxime or TMB-4, is an oxime used in the treatment of organophosphate poisoning[1] It is chemically related to asoxime, pralidoxime, and obidoxime.[2]

References

[edit]
  1. Dhuguru J, Zviagin E, Skouta R (January 2022). "FDA-Approved Oximes and Their Significance in Medicinal Chemistry". Pharmaceuticals. 15 (1). Basel, Switzerland: 66. doi:10.3390/ph15010066. PMC 8779982. PMID 35056123.
  2. Gupta R, Parmar M (2022). "Pralidoxime". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32644334.